Jingde Wu

1.4k total citations
37 papers, 1.2k citations indexed

About

Jingde Wu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Jingde Wu has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in Jingde Wu's work include Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (8 papers) and Click Chemistry and Applications (6 papers). Jingde Wu is often cited by papers focused on Histone Deacetylase Inhibitors Research (12 papers), Protein Degradation and Inhibitors (8 papers) and Click Chemistry and Applications (6 papers). Jingde Wu collaborates with scholars based in China, United States and Belgium. Jingde Wu's co-authors include Glenn Merlino, N Fausto, Jiahui Lv, Qiuqiong Zhang, Feng He, Chenggong Yu, Xiangna Zhang, Ying Qu, Yingying Ran and Zhaopeng Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Jingde Wu

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingde Wu China 19 635 243 163 146 125 37 1.2k
Caiping Tian China 20 690 1.1× 195 0.8× 110 0.7× 137 0.9× 54 0.4× 29 1.3k
Qiwei Jiang China 27 1.1k 1.7× 80 0.3× 132 0.8× 421 2.9× 86 0.7× 61 1.9k
Chong Zhao China 22 667 1.1× 102 0.4× 66 0.4× 253 1.7× 52 0.4× 47 1.1k
Chang Su China 22 536 0.8× 81 0.3× 225 1.4× 137 0.9× 26 0.2× 43 1.2k
Tingting Fan China 25 919 1.4× 103 0.4× 113 0.7× 161 1.1× 32 0.3× 65 1.5k
Tae Gyu Lee South Korea 18 740 1.2× 132 0.5× 37 0.2× 91 0.6× 113 0.9× 37 1.2k
Fan Feng China 26 945 1.5× 159 0.7× 64 0.4× 334 2.3× 42 0.3× 66 1.8k

Countries citing papers authored by Jingde Wu

Since Specialization
Citations

This map shows the geographic impact of Jingde Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingde Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingde Wu more than expected).

Fields of papers citing papers by Jingde Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingde Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingde Wu. The network helps show where Jingde Wu may publish in the future.

Co-authorship network of co-authors of Jingde Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingde Wu. A scholar is included among the top collaborators of Jingde Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingde Wu. Jingde Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qianlong, Hongyan Liu, Jie Peng, et al.. (2024). HDAC8 as a target in drug discovery: Function, structure and design. European Journal of Medicinal Chemistry. 280. 116972–116972. 2 indexed citations
2.
Ran, Yingying, et al.. (2023). Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer’s disease. Bioorganic & Medicinal Chemistry. 80. 117178–117178. 18 indexed citations
3.
Peng, Jie, Fei Xie, Yujing Liu, et al.. (2023). Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design. Bioorganic Chemistry. 138. 106622–106622. 20 indexed citations
4.
Ran, Yingying, et al.. (2022). Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease. Bioorganic Chemistry. 128. 106090–106090. 21 indexed citations
5.
Zhang, Xiangna, et al.. (2022). Design, synthesis and biological evaluation of phenyl vinyl sulfone based NLRP3 inflammasome inhibitors. Bioorganic Chemistry. 128. 106010–106010. 7 indexed citations
6.
Zhang, Chengmei, et al.. (2021). A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy. European Journal of Medicinal Chemistry. 228. 114037–114037. 11 indexed citations
7.
Wang, Xiuxiu, Fei Xie, Ning Yan, et al.. (2021). Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease. European Journal of Medicinal Chemistry. 225. 113821–113821. 16 indexed citations
8.
He, Feng, Yingying Ran, Xiaoyang Li, et al.. (2020). Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease. Bioorganic Chemistry. 103. 104109–104109. 18 indexed citations
9.
He, Feng, Xiangna Zhang, Xiaoyang Li, et al.. (2020). Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: Design, synthesis, and biological evaluation. Bioorganic Chemistry. 98. 103721–103721. 26 indexed citations
10.
Wu, Jingde, et al.. (2019). Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease. European Journal of Medicinal Chemistry. 167. 211–225. 41 indexed citations
11.
Lv, Jiahui, Jingde Wu, Feng He, et al.. (2018). Development of Bruton’s Tyrosine Kinase Inhibitors for Rheumatoid Arthritis. Current Medicinal Chemistry. 25(42). 5847–5859. 20 indexed citations
12.
Yu, Chenggong, Feng He, Ying Qu, et al.. (2018). Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap. Bioorganic & Medicinal Chemistry. 26(8). 1859–1868. 9 indexed citations
13.
Li, Xiaoyang, Yingjie Zhang, Yuqi Jiang, et al.. (2017). Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study. European Journal of Medicinal Chemistry. 134. 185–206. 32 indexed citations
14.
He, Feng, et al.. (2017). Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors. Bioorganic & Medicinal Chemistry. 25(15). 4123–4132. 20 indexed citations
15.
Jiang, Yuqi, Xiaoyang Li, Yongxue Huang, et al.. (2016). Discovery of a novel chimeric ubenimex–gemcitabine with potent oral antitumor activity. Bioorganic & Medicinal Chemistry. 24(22). 5787–5795. 17 indexed citations
16.
Li, Xiaoyang, Jingde Wu, Xiaoguang Li, et al.. (2015). Development of N-hydroxybenzamide derivatives with indole-containing cap group as histone deacetylases inhibitors. Bioorganic & Medicinal Chemistry. 23(19). 6258–6270. 15 indexed citations
17.
Li, Wenjun, Jingde Wu, Peng Zhan, et al.. (2012). Synthesis, drug release and anti-HIV activity of a series of PEGylated zidovudine conjugates. International Journal of Biological Macromolecules. 50(4). 974–980. 17 indexed citations
18.
Chen, Wen‐Ming, Peng Zhan, Jingde Wu, Zhenyu Li, & Xinyong Liu. (2012). The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family. Current Pharmaceutical Design. 18(27). 4165–4186. 14 indexed citations
19.
Zhang, Jing, Peng Zhan, Jingde Wu, et al.. (2011). Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 19(14). 4366–4376. 30 indexed citations
20.
Li, Qianbin, Jingde Wu, Hui Zheng, et al.. (2010). Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorganic & Medicinal Chemistry Letters. 20(15). 4526–4530. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caiping Tian Breakdown of academic impact, for papers by Qiwei Jiang Breakdown of academic impact, for papers by Chong Zhao Breakdown of academic impact, for papers by Chang Su Breakdown of academic impact, for papers by Tingting Fan Breakdown of academic impact, for papers by Tae Gyu Lee Breakdown of academic impact, for papers by Fan Feng
Rankless by CCL
2026